Wolverine Trading’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$288K Buy
+5,100
New +$294K ﹤0.01% 4440
2025
Q2
Sell
-4,900
Closed -$355K 5065
2025
Q1
$355K Buy
+4,900
New +$405K ﹤0.01% 3341
2021
Q2
Sell
-6,800
Closed -$415K 6261
2021
Q1
$415K Buy
+6,800
New +$431K ﹤0.01% 3992
2020
Q4
Sell
-5,500
Closed -$269K 5033
2020
Q3
$269K Sell
5,500
-5,800
-51% -$299K ﹤0.01% 3522
2020
Q2
$536K Buy
+11,300
New +$545K ﹤0.01% 2663
2020
Q1
Sell
-15,800
Closed -$928K 4849
2019
Q4
$928K Buy
+15,800
New +$858K ﹤0.01% 2481
2019
Q1
Sell
-12,500
Closed -$537K 4791
2018
Q4
$537K Sell
12,500
-1,100
-8% -$54.9K ﹤0.01% 2557
2018
Q3
$772K Sell
13,600
-11,200
-45% -$589K ﹤0.01% 2624
2018
Q2
$1.24M Hold
24,800
﹤0.01% 2040
2018
Q1
$1.24M Buy
+24,800
New +$1.17M ﹤0.01% 2040
2017
Q2
Sell
-9,300
Closed -$273K 4521
2017
Q1
$273K Sell
9,300
-100
-1% -$2.73K ﹤0.01% 3147
2016
Q4
$233K Sell
9,400
-3,800
-29% -$86.4K ﹤0.01% 3560
2016
Q3
$295K Buy
13,200
+4,000
+43% +$94K ﹤0.01% 3259
2016
Q2
$219K Buy
+9,200
New +$221K ﹤0.01% 3178

Other funds holding GMED

Wolverine Trading's GMED Position: Q3 2025 in Review

Wolverine Trading opened a new position in Globus Medical (GMED) in Q3 2025: 9,743 shares worth $550K. The stake represents ﹤0.01% of the portfolio and ranks #3603 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in GMED as recently as Q1 2024.

Wolverine Trading first reported a position in GMED in Q4 2017 and has held it in 8 quarters since. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Wolverine Trading held 9,743 shares of Globus Medical worth $550K as of Q3 2025.
  • Globus Medical was a new Wolverine Trading position in Q3 2025.
  • Globus Medical made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3603 holding.
  • Wolverine Trading first reported a position in Globus Medical in Q4 2017 and has held it in 8 quarters since.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.